Jacolien van der Marel
Research Subjects
Jacolien van der Marel has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Jaume Ordi
Department of Pathology, Hospital Clínic University of Barcelona Barcelona Spain
3 shared publications A Torné
Institut Clinic of Gynecology, Obstetrics and Neonatology Hospital Clínic‐Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain
1 shared publicationA. Rodriguez
Institut Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/Villaroel 170, Barcelona, Spain
1 shared publicationA. Torné
Institut Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/Villaroel 170, Barcelona, Spain
1 shared publicationAureli Torné
Institut Clinic of Gynecology, Obstetrics and Neonatology, IDIBAPS (Institut d´Investigacions Biomèdiques August Pi i Sunyer)-Hospital Clínic
1 shared publicationB ter Harmsel
Department of Obstetrics and Gynaecology Reinier de Graaf Groep Delft the Netherlands
1 shared publication
Latest Publications
- 1 November 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 135 (2) , 201-207
The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy
- 1 November 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 135 (2) , 201-207
The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy
- 1 April 2014
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 38 (4) , 470-479
Oncogenic Human Papillomavirus–infected Immature Metaplastic Cells and Cervical Neoplasia
Persistent cervical high-risk human papillomavirus (HR-HPV) infection results in high-grade cervical intraepithelial neoplasia (CIN2/3) and cervical carcinoma. The susceptibility of the cervix to HPV carcinogenesis and the importance of HPV18 in cervical carcinoma despite relative infrequency in CIN2/3 could be linked to HR-HPV infection of immature metaplasia (IM) at the squamocolumnar junction. Atypical IM (AIM) is an equivocal category used to describe changes in IM suggestive of high-grade neoplasia, which causes diagnostic and management problems. We used laser capture microscopy combined with polymerase chain reaction in 24 women with HPV18, HPV16, or other HPV infections on cytologic analysis and a cervical loop electrosurgical excision procedure to locate HR-HPV in cervical tissue. HPV18-positive AIM and CIN2/3 were present in 7/12 cases with HPV18 on cytologic analysis. In 2 cases with HPV18 and other HPV types, HPV18 was only present in AIM and not in CIN2/3. HPV16-positive AIM was present in 3/7 and HPV16-positive CIN2/3 in 5/7 cases with HPV16. No cases had HPV16 AIM without CIN2/3. Other HR-HPV-positive AIM and CIN2/3 cases were present, respectively, in 1/6 and 5/6 cases positive for HR-HPV types other than HPV16/18. In a subset, 94% HPV18 AIM regions showed CK17 and p16 positivity, and 41% were CK7 positive. CIN2/3 and AIM with other HR-HPVs showed similar patterns. AIM was a particular feature of HPV18 infection in women with CIN2/3. HR-HPV infection of CK7/17-positive AIM expressing p16 was particularly seen for HPV18 with and without classical CIN2/3 and should be regarded as a high-grade precancer.
- 1 April 2014
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 38 (4) , 470-479
Oncogenic Human Papillomavirus–infected Immature Metaplastic Cells and Cervical Neoplasia
Persistent cervical high-risk human papillomavirus (HR-HPV) infection results in high-grade cervical intraepithelial neoplasia (CIN2/3) and cervical carcinoma. The susceptibility of the cervix to HPV carcinogenesis and the importance of HPV18 in cervical carcinoma despite relative infrequency in CIN2/3 could be linked to HR-HPV infection of immature metaplasia (IM) at the squamocolumnar junction. Atypical IM (AIM) is an equivocal category used to describe changes in IM suggestive of high-grade neoplasia, which causes diagnostic and management problems. We used laser capture microscopy combined with polymerase chain reaction in 24 women with HPV18, HPV16, or other HPV infections on cytologic analysis and a cervical loop electrosurgical excision procedure to locate HR-HPV in cervical tissue. HPV18-positive AIM and CIN2/3 were present in 7/12 cases with HPV18 on cytologic analysis. In 2 cases with HPV18 and other HPV types, HPV18 was only present in AIM and not in CIN2/3. HPV16-positive AIM was present in 3/7 and HPV16-positive CIN2/3 in 5/7 cases with HPV16. No cases had HPV16 AIM without CIN2/3. Other HR-HPV-positive AIM and CIN2/3 cases were present, respectively, in 1/6 and 5/6 cases positive for HR-HPV types other than HPV16/18. In a subset, 94% HPV18 AIM regions showed CK17 and p16 positivity, and 41% were CK7 positive. CIN2/3 and AIM with other HR-HPVs showed similar patterns. AIM was a particular feature of HPV18 infection in women with CIN2/3. HR-HPV infection of CK7/17-positive AIM expressing p16 was particularly seen for HPV18 with and without classical CIN2/3 and should be regarded as a high-grade precancer.
- 4 February 2014
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 121 (9) , 1117-1126
The impact of human papillomavirus genotype on colposcopic appearance: a cross‐sectional analysis
Objective: To study colposcopic performance in diagnosing high‐grade cervical intraepithelial neoplasia or cervical cancer (CIN2+ and CIN3+) using colposcopic characteristics and high‐risk human papillomavirus (hrHPV) genotyping.Design: Cross‐sectional multicentre study.Setting: Two colposcopy clinics in The Netherlands and Spain.Population: Six hundred and ten women aged 17 years and older referred for colposcopy because of abnormal cytology.Methods: A cervical smear was obtained. Colposcopists identified the worst lesion, graded their impression and scored the colposcopic characteristics of the lesions. Up to four biopsies were collected, including one biopsy from visually normal tissue.Main outcome measures: CIN2+ and CIN3+, positive for HPV16 or other high‐risk HPV types (non‐16 hrHPV‐positive).Results: The mean age in HPV16‐positive CIN2+ women was 35.1 years compared with 39.1 years in women with other hrHPV types (P = 0.002). Sensitivity for colposcopy to detect CIN2+ was 87.9% (95%CI 83.2–91.5), using colposcopic cut‐off of ‘any abnormality’. The remaining CIN2+ were found by a biopsy from visually normal tissue or endocervical curettage (ECC). Detection of CIN2+ by lesion‐targeted biopsies was not different between HPV16‐positive women [119/135; 88.1% (95%CI 81.2–92.9)] and non‐16 hrHPV‐positive women [100/115; 87.0% (95%CI 79.1–92.3); P = 0.776]. In multivariate analysis, ‘acetowhitening’ [odds ratio (OR) 1.91, 95%CI 1.56–3.17], ‘time of appearance’ (OR 1.95, 95%CI 1.21–3.15) and ‘lesion >25% of visible cervix’ (OR 2.25, 95%CI 1.44–3.51) were associated with CIN2+.Conclusions: In this population following European screening practice, HPV16‐related CIN2+ lesions were detected at younger age and showed similar colposcopic impression as non‐16 hrHPV high‐grade lesions. There was no relationship between any of the colposcopic characteristics and HPV16 status.
- 4 February 2014
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 121 (9) , 1117-1126
The impact of human papillomavirus genotype on colposcopic appearance: a cross‐sectional analysis
Objective: To study colposcopic performance in diagnosing high‐grade cervical intraepithelial neoplasia or cervical cancer (CIN2+ and CIN3+) using colposcopic characteristics and high‐risk human papillomavirus (hrHPV) genotyping.Design: Cross‐sectional multicentre study.Setting: Two colposcopy clinics in The Netherlands and Spain.Population: Six hundred and ten women aged 17 years and older referred for colposcopy because of abnormal cytology.Methods: A cervical smear was obtained. Colposcopists identified the worst lesion, graded their impression and scored the colposcopic characteristics of the lesions. Up to four biopsies were collected, including one biopsy from visually normal tissue.Main outcome measures: CIN2+ and CIN3+, positive for HPV16 or other high‐risk HPV types (non‐16 hrHPV‐positive).Results: The mean age in HPV16‐positive CIN2+ women was 35.1 years compared with 39.1 years in women with other hrHPV types (P = 0.002). Sensitivity for colposcopy to detect CIN2+ was 87.9% (95%CI 83.2–91.5), using colposcopic cut‐off of ‘any abnormality’. The remaining CIN2+ were found by a biopsy from visually normal tissue or endocervical curettage (ECC). Detection of CIN2+ by lesion‐targeted biopsies was not different between HPV16‐positive women [119/135; 88.1% (95%CI 81.2–92.9)] and non‐16 hrHPV‐positive women [100/115; 87.0% (95%CI 79.1–92.3); P = 0.776]. In multivariate analysis, ‘acetowhitening’ [odds ratio (OR) 1.91, 95%CI 1.56–3.17], ‘time of appearance’ (OR 1.95, 95%CI 1.21–3.15) and ‘lesion >25% of visible cervix’ (OR 2.25, 95%CI 1.44–3.51) were associated with CIN2+.Conclusions: In this population following European screening practice, HPV16‐related CIN2+ lesions were detected at younger age and showed similar colposcopic impression as non‐16 hrHPV high‐grade lesions. There was no relationship between any of the colposcopic characteristics and HPV16 status.